Trexquant Investment LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,184,769
+1378.0%
274,252
+2154.6%
0.03%
+1400.0%
Q2 2023$80,161
-76.1%
12,164
-75.4%
0.00%
-77.8%
Q1 2023$335,813
-26.4%
49,457
-19.9%
0.01%
-30.8%
Q4 2022$456,273
+44.8%
61,742
+93.4%
0.01%
+18.2%
Q3 2022$315,000
-0.3%
31,922
+10.2%
0.01%
-21.4%
Q2 2022$316,000
-60.2%
28,974
-58.7%
0.01%
-62.2%
Q1 2022$794,000
+74.9%
70,177
+142.6%
0.04%
+32.1%
Q4 2021$454,000
+96.5%
28,923
+87.9%
0.03%
+33.3%
Q1 2021$231,000
+18.5%
15,393
+3.9%
0.02%0.0%
Q4 2020$195,000
-62.4%
14,818
-72.4%
0.02%
-36.4%
Q3 2020$519,000
-10.1%
53,729
+6.5%
0.03%
-17.5%
Q2 2020$577,000
+45.7%
50,462
+69.3%
0.04%
+17.6%
Q3 2019$396,000
+32.4%
29,800
+40.6%
0.03%
+25.9%
Q2 2019$299,000
-42.9%
21,192
-7.2%
0.03%
-30.8%
Q3 2018$524,000
+147.2%
22,837
+104.7%
0.04%
+160.0%
Q2 2018$212,000
-44.8%
11,154
-52.7%
0.02%
-85.7%
Q2 2017$384,000
+107.6%
23,568
+112.3%
0.10%
+156.1%
Q3 2016$185,000
-65.2%
11,100
-80.5%
0.04%
-12.8%
Q4 2015$531,000
-27.2%
57,005
-27.3%
0.05%
-36.5%
Q1 2015$729,00078,4000.07%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders